Global Stent Grafts Market 2015-2019
|発行||TechNavio (Infiniti Research Ltd.)||商品コード||348024|
|出版日||ページ情報||英文 68 Pages
|ステントグラフトの世界市場：2015年〜2019年 Global Stent Grafts Market 2015-2019|
|出版日: 2015年12月23日||ページ情報: 英文 68 Pages||
A stent graft is a tube composed of fabric supported by a metal mesh called a stent. It is delivered using a catheter and is basically used for reinforcing a weak spot in the artery, called an aortic aneurysm. The ability of stent grafts to treat complex diseases such as juxtarenal and pararenal aneurysms, and iliac disease is a significant factor that propels market growth during the forecast period. This market is expected to post a steady market growth rate of more than 6% by 2019 owing to the growing incidence of aortic aneurysm among the aging population.
Increasing incidence of cardiac disorders is a significant factor that is expected to drive market growth during the forecast period. Due to unhealthy diet and physical inactivity, the number of people suffering from cardiac disorders is expected to increase. This recent increase in the incidence of cardiac disorders is expected to boost the demand for stent grafts during the forecast period.
Technavio's market research analyst has estimated the abdominal aortic aneurysm (AAA) stent grafts segment to account for more than 82% of the total market share by 2019. These stent grafts are useful in treating AAA and function by attaching itself to the aorta wall in a spring like fashion.
In this market research report, analysts estimate the Americas to dominate the global market for stent grafts followed by the EMEA and the APAC regions. High incidence of aortic aneurysm in the US is responsible for this region's high market dominion during the forecast period.
This market is well organized and is highly competitive due to the presence of multiple vendors. The dominant vendors account for a major share of the market during the forecast period and face occasional competition from local manufacturers in various countries.
Other prominent vendors in this market include Aptus Endosystem, Bolton Medical, Cordis, GRIKIN Advanced Materials, LifeTech Scientific, Lombard Medical, St. George Medical, Terumo (Vascutek), TriVascular, WL Gore & Associates, Bolton Medical, Endologix, Johnson & Johnson, Jotec, Lombard Medical Technologies, Terumo, and TriVascular Technologies.